The vaccines currently used in the US still offer strong protection against severe disease and death, especially if people have gotten their recommended boosters. [iStockphoto]
Pfizer asked U.S. regulators Monday to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives - a key step toward opening a fall booster campaign.